Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Over the past several months, advancements in artificial intelligence (AI) have led some high-profile companies to attempt to ...

Looks like Ford, the multinational automobile manufacturer, is rethinking its decision to replace human engineers with AI.

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...